An In Vitro Comparative Study on the Reactivation of Nerve Agent-Inhibited Guinea Pig and Human Acetylcholinesterases by Oximes

Department of Molecular Pharmacology, Division of Biochemistry, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, USA.
Biochemistry (Impact Factor: 3.02). 11/2007; 46(42):11771-9. DOI: 10.1021/bi701002f
Source: PubMed


The reactivation of nerve agent-inhibited acetylcholinesterase (AChE) by oxime is the most important step in the treatment of nerve agent poisoning. Since the evaluation of nerve agent antidotes cannot be conducted in humans, results from animal experiments are extrapolated to humans. Guinea pig is one of the animal models that is frequently used for conducting nerve agent antidote evaluations. Several investigations have demonstrated that the efficacy of an oxime primarily depends on its ability to reactivate nerve agent-inhibited AChE. If the in vitro oxime reactivation of nerve agent-inhibited animal AChE is similar to that of human AChE, it is likely that the results of an in vivo animal study will reliably extrapolate to humans. Therefore, the goal of this study was to compare the reactivation of guinea pig and human AChEs inhibited by six different G and V type nerve agents. Reactivation kinetic studies with five mono- and bis-pyridinium oximes showed that oxime reactivation of nerve agent-inhibited human AChE in most cases was faster than guinea pig AChE. The most significant enhancement was observed in the reactivation of human AChE inhibited by nerve agents containing bulky side chains GF, GD, and VR, by H-series oximes HLo-7, HI-6, and ICD-585. In these cases, species-related differences observed between the two AChEs, based on the second-order reactivation rate constants, were 90- to over 400-fold. On the other hand, less than 3-fold differences were observed in the rates of aging of nerve agent-inhibited guinea pig and human AChEs. These results suggest that the remarkable species-related differences observed in the reactivation of nerve agent-inhibited guinea pig and human AChEs were not due to differences in the rates of aging. These results also suggest that guinea pig may not be an appropriate animal model for the in vivo evaluation of oxime therapy.

Download full-text


Available from: Chunyuan Luo, Jun 19, 2014
  • Source
    • "In a recent study, we demonstrated that species-related variations in oxime reactivation between guinea pig AChE and recombinant human AChE (rHu AChE) were especially pronounced with nerve agents containing bulky side-chains such as GF, GD, and VR when H-series oximes (HI-6 and HLo-7) were used as reactivators. In these cases, the reactivation of guinea pig AChE was 180-to 430-fold slower than rHu AChE [20]. Since guinea pig is frequently used as an animal model for the evaluation of nerve agent antidotes, it raises a concern regarding the suitability of this animal model for predicting the efficacy of oximes in humans. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Human serum butyrylcholinesterase (Hu BChE) is currently the most appropriate candidate for the prophylaxis of humans against organophosphate (OP) nerve agent toxicity. It is estimated that a dose of 200 mg will protect a human against 2× LD50 of soman, which means that gram quantities of enzyme are needed for human clinical studies. Toward this effort, we report the development of the first procedure that is suitable for the pilot-scale purification of Hu BChE from Cohn fraction IV-4 paste. This procedure involved resuspension of Cohn fraction IV-4 paste, followed by procainamide affinity and DEAE anion-exchange chromatography. The procedure yielded 6–7 g (4.3–5 million U) of purified enzyme from 80 kg of Cohn fraction IV-4 paste. The enzyme was >97% pure as judged by a specific activity of ∼700 U/mg and a major band with a subunit molecular weight of 85 kDa on SDS-PAGE. The high yield and purity obtained suggest that this manufacturing procedure is suitable for the pre-clinical production of Hu BChE.
    PROCESS BIOCHEMISTRY 08/2010; 45(8):1313-1318. DOI:10.1016/j.procbio.2010.04.021 · 2.52 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Organophosphorus chemical warfare nerve agents are potent inhibitors of the enzyme acetylcholinesterase (AChE). Inhibition of AChE at nerve terminals in peripheral tissues and the central nervous system (CNS) results in acetylcholine (ACh) overload and, depending on the extent of enzyme inhibition, cholinergic crisis. Current treatment strategies for nerve agent intoxication consist of using an oxime such as pyridine-2-aldoxime methylchloride (2-PAM) to reactivate the inhibited AChE and the anticholinergic drug atropine sulfate to antagonize the effects of excess ACh at muscarinic cholinergic receptors.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cholinesterases (ChEs) are classified as either acetylcholinesterase (AChE) or butyrylcholinesterase (BChE) based on their substrate and inhibitor specificity. Organophosphate and carbamate compounds commonly represented by herbicides, pesticides, and nerve gases irreversibly inhibit ChEs. Therefore, exposure to organophosphates and carbamates is normally assessed by measuring ChE activity in blood. There are two approaches for measuring AChE and BChE activity present in whole blood: (1) separating blood into erythrocytes, which contain only AChE, and plasma which contains only BChE, to measure their activity individually, or (2) use a BChE-specific inhibitor to measure the activity of AChE in whole blood. A number of studies have reported the use of different inhibitors for the simultaneous measurement of AChE and BChE activities. However, the inhibitors used for completely inhibiting BChE activity also inhibited AChE activity leading to errors in reported values. The goal of this study was to find the most accurate and simple method for the simultaneous determination of AChE and BChE activity in animal whole blood. Solutions containing human AChE and BChE in various proportions were prepared and AChE and BChE activities were measured using three reported methods. Results demonstrate that ethopropazine and (-) huperzine A appear to be the most specific ChE inhibitors. Preliminary results with human and animal whole blood suggest that 20 microM ethopropazine and 500 nM (-) huperzine A can be used for measuring AChE and BChE activities across species.
    Chemico-Biological Interactions 06/2008; 175(1-3):298-302. DOI:10.1016/j.cbi.2008.05.002 · 2.58 Impact Factor
Show more